Related Experiment Video
Updated: Aug 4, 2026

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
Differential expression of the splicing regulatory factor genes during two-step chemical transformation in a
1Department of Radiology and Radiation Oncology, Osaka University School of Dentistry, 1-8 Yamadaoka, Suita, Osaka 565-0871, Japan. tmaeda@radiol.dent.osaka-u.ac.jp
Abstract:
Although the alternative splicing of various genes is a common event in human tumors, the mechanisms behind it have not been characterized. We hypothesized that the expression of splicing regulatory factors would be changed during cellular transformation. Gene expression of three splicing regulatory factors, alternative splicing factor/splicing factor 2 (ASF/SF2), heterogeneous nuclear ribonucleoprotein A2 (hnRNP A2) and the 65 kDa subunit of U2 small nuclear ribonucleoprotein particles auxiliary factor (U2AF(65)), were examined by northern blotting in a two-step chemical transformation model. This in vitro model is composed of BALB/3T3 cells and a BALB/3T3-derived N-methyl-N-nitro-N-nitrosoguanidine (MNNG)-initiated cell line (MT-5). MT-5 cells can be transformed on exposure to 12-O-tetradecanoylphorbol-13-acetate (TPA). ASF/SF2 mRNA levels were decreased 2-fold in both MNNG-initiated cells and TPA-induced transformed cells compared with the normal parental cells, whereas hnRNP A2 mRNA expression did not significantly change between these three types of cells. U2AF(65) mRNA levels were markedly increased ( approximately 4.7-fold) associated with progression of cellular transformation. Moreover, RT-PCR analysis showed that distinct forms of ASF/SF2 mRNA were present in the MNNG-initiated cells and TPA-induced transformed cells but not in the parental cells. These findings indicate that ASF/SF2 or U2AF(65) gene expression is altered during in vitro two-step chemical transformation. The data suggest that the differential expression of splicing regulatory factors is one cause of aberrant expression of alternatively spliced mRNAs encoded by various genes in tumor cells.
Insights
Changes in splicing factor gene expression, including alternative splicing factor/splicing factor 2 (ASF/SF2) and U2 small nuclear ribonucleoprotein particles auxiliary factor 65 (U2AF(65)), occur during cellular transformation, potentially explaining aberrant alternative splicing in tumors.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Alternative splicing is frequently altered in human tumors.
- The underlying mechanisms driving these splicing changes during cancer development are not well understood.
- Splicing regulatory factors play a crucial role in controlling alternative splicing patterns.
Purpose of the Study:
- To investigate alterations in the expression of key splicing regulatory factors during in vitro cellular transformation.
- To determine if changes in splicing factor gene expression correlate with the progression of cancer development.
- To explore the potential link between altered splicing factor expression and aberrant alternative splicing observed in tumor cells.
Main Methods:
- Utilized a two-step chemical transformation model using BALB/3T3 cells and derived cell lines (MT-5).
- Examined mRNA expression levels of splicing regulatory factors, including alternative splicing factor/splicing factor 2 (ASF/SF2), heterogeneous nuclear ribonucleoprotein A2 (hnRNP A2), and U2 small nuclear ribonucleoprotein particles auxiliary factor 65 (U2AF(65)), via Northern blotting.
- Analyzed distinct mRNA isoforms using Reverse Transcription Polymerase Chain Reaction (RT-PCR).
Main Results:
- ASF/SF2 mRNA levels decreased significantly (2-fold) in both initiated and transformed cells compared to parental cells.
- hnRNP A2 mRNA expression showed no significant changes across the cell types.
- U2AF(65) mRNA levels increased substantially (approximately 4.7-fold) with the progression of cellular transformation.
- Distinct ASF/SF2 mRNA variants were detected in initiated and transformed cells, but not in parental cells.
Conclusions:
- Gene expression of ASF/SF2 and U2AF(65) is demonstrably altered during in vitro chemical-induced cellular transformation.
- Differential expression of splicing regulatory factors like ASF/SF2 and U2AF(65) is implicated as a causative factor for aberrant alternative splicing in tumor cells.
- These findings provide mechanistic insights into how altered splicing contributes to cancer development.
Related Concept Videos
RNA Splicing
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
What is Gene Expression?
Forced Transdifferentiation
Artificial transdifferentiation occurs...
Regulation of Expression at Multiple Steps

